Trials / Unknown
UnknownNCT00240604
Prevention of Corticosteroid-induced Glucose Intolerance
Treatment With Rosiglitazone for the Prevention of Glucose Intolerance in Patients Treated With Corticosteroids
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Hadassah Medical Organization · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Glucose intolerance is frequent and serious complication of corticosteroid therapy. the aim of the study is to examine the hypothesis that co treatment with rosiglitazone can prevent glucose intolerance in patients treated with corticosteroids.
Detailed description
Glucose intolerance is frequent and serious complication of corticosteroid therapy. the aim of the study is to examine the hypothesis that co treatment with rosiglitazone can prevent glucose intolerance in patients treated with corticosteroids.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rosiglitazone | 4 mg rosiglitazone per day |
Timeline
- Start date
- 2005-04-01
- Primary completion
- 2013-12-01
- Completion
- 2015-10-01
- First posted
- 2005-10-18
- Last updated
- 2011-09-14
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00240604. Inclusion in this directory is not an endorsement.